source
- Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelicsLilly shares dipped, and Novo’s climbed, as Foundayo’s early trajectory diverged from that of oral Wegovy. Elsewhere, Regeneron inked a drug price deal and two companies announced leadership changes.BioPharma Dive · 3mo ago↗ source
- Exclusive: UC Berkeley startup bets on jumping genes for GLP-1 gene therapyThe new generation of weight loss medicines does an unprecedented job of keeping off the pounds — if people stay on the drugs. Yet numerous studies suggest most of those who start taking GLP-1 drug…Endpoints · 3mo ago↗ source
- Sanofi’s tolebrutinib gets CHMP backing for certain MS patients despite FDA rejectionSanofi’s tolebrutinib is on track to get an approval in Europe for a type of multiple sclerosis even after receiving a complete response letter from the FDA in December. On Friday, the European Med…